To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.
Bill journey · stage 1 of 5
Just introduced
What it doesSummary introduced in house (Apr 3, 2019)
This bill requires drug manufacturers to provide the Department of Health and Human Services with aggregate data related to product samples of drugs, devices, biologic products, and medical supplies given to hospitals, physicians, or other medical professionals during the previous calendar year, beginning in 2023.
What just happenedMay 21, 2019
Subcommittee Hearings Held.
Who’s behind it
- Introduced in HouseApr 3, 2019
- May 21, 2019Committee
Subcommittee Hearings Held.
Health Subcommittee - Apr 4, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Apr 3, 2019Committee
Referred to the Subcommittee on Health.
Ways and Means CommitteeHealth Subcommittee - Apr 3, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Apr 3, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Apr 3, 2019IntroReferralIntro-H
Introduced in House
- Apr 3, 2019IntroReferral1000
Introduced in House